By Jacob Gronholt-Pedersen and Stine Jacobsen

COPENHAGEN (Reuters) -Novo Nordisk’s top shareholder forced through an overhaul of the Wegovy-maker’s board at a shareholder meeting on Friday, asserting control in a move that sparked protests by some investors over governance concerns.

The boardroom shake-up, which erupted when Novo’s board Chair Helge Lund and the independent members stepped down last month under pressure, has handed unprecedented power to the Novo Nordisk Foundation, which controls 77% of Novo’s voting rights.

“It was not possible to reach a common understanding with the Novo Nordisk Foundation regarding governance principles and the future composition of the of the board of Novo Nordisk,” Lund told shareholders.

The foundation’s chairman, former Novo Nordisk CEO Lars R

See Full Page